BLS Clinic Director Lee Dong-jin attends the '2026 Titanium Master Summit'… next-generation Hyper Titanium technology and clinical experience shared

Dr. Lee Dong-jin, Chief Director of BLS Clinic Main Branch, attended the '2026 Titanium Master Summit, Hyper Titanium Launch Edition,' hosted on October 17, 2026 by Alma Korea, a global medical aesthetics company, and took part in an academic exchange with Korean aesthetic medicine professionals examining the latest laser technology and its potential clinical applications.

Held at Le Ciel 31 on the 31st floor of the Seoul Dragon City hotel, the event was organized to celebrate the fifth anniversary of the Korean launch of Soprano Titanium and to announce the official launch of the next-generation Hyper Titanium.

According to a Biotimes report, about 300 medical professionals attended the event, and an academic program was held to share clinical experience and treatment know-how with Soprano Titanium and the potential applications of new laser technology.

Hyper Titanium: how does it differ from the existing Soprano Titanium?

The main topic of this Titanium Master Summit was the newly unveiled Hyper Titanium.

Hyper Titanium advances the technology of the existing Soprano Titanium and is based on a diode laser system that emits three wavelengths, 755nm, 810nm, and 1064nm, simultaneously.

On its official site, Alma Korea introduces Hyper Titanium as 'a new Titanium protocol using Dual Tips (2cm² + 4cm²).'

In Korea, Soprano Titanium is a Class 3 medical device, a 'diode (semiconductor) laser surgical device' (import license No. 20-88), approved by the Ministry of Food and Drug Safety (MFDS) in 2020. The importer is Alma Korea and the manufacturer is Alma Lasers of Israel, and the product information can be looked up by license number on the MFDS medical device e-civil service portal.

Alma Lasers is a medical device company founded in Israel in 1999 and a wholly owned subsidiary of Sisram Medical, a company listed on the Hong Kong Stock Exchange (Sisram Medical 2025 Annual Report).

However, a new protocol does not by itself mean clinical results superior to existing methods. Actual safety and clinical usefulness need to be evaluated through clinical data accumulated going forward.

Korean aesthetic medicine professionals discuss strategies for the clinical use of Hyper Titanium

Going beyond a simple new product announcement, the event was organized as a forum for academic exchange in which medical professionals examined real clinical experience with Soprano Titanium and discussed its future development.

In the Master Session, Director Jung Un-gyeong of U&Jung Dermatology Clinic and Director Shim Jun-ho of Benjamin Dermatology Clinic Myeongdong Branch took part as speakers, and in the TMM Insight session, Director Lee Do-yeong of Hill House Dermatology Clinic, Director Choi Seon-cheol of Cheongdam Flex Dermatology Clinic, Director Yoo Dong-gi of Irvine Dermatology Clinic, and Director Park Ju-hyeok of The Hill Dermatology Clinic Sinsa Branch took part as speakers.

The lectures covered energy-use strategies and treatment experience with Titanium lasers, as well as the technical features and potential applications of Hyper Titanium. In a panel discussion chaired by Director Lee Sang-jun of Areumdaunnara Dermatology Clinic, a range of views were also shared among medical professionals.

Chief Director Lee Dong-jin of BLS Clinic Main Branch also attended this Titanium Master Summit, examining changes in the latest laser device technology and the clinical approaches of Korean medical professionals.

Participation in the event is meaningful as an opportunity to understand new aesthetic medicine technology and share the experiences and perspectives of different medical professionals.

Director Lee Dong-jin's interest in learning the latest technology and in academic exchange among medical professionals

In energy-based aesthetic procedures, it is important to consider comprehensively not only the technical characteristics of the device itself but also the patient's skin condition, treatment goals, and the anatomical features of the treatment area.

Laser procedures in particular call for ongoing technical understanding and clinical review, as multiple factors such as wavelength, energy settings, and delivery method can affect treatment results and safety.

The attendance of Dr. Lee, Chief Director of BLS Clinic Main Branch, at this Titanium Master Summit can likewise be seen as an extension of this academic interest. Dr. Lee has given lectures at academic conferences in Korea and abroad since 2025.

• October 11, 2026: delivered a lecture and served as session chair at the Korean Obesity, Regenerative & Aesthetic Society (KORA) Autumn Conference
• May 10, 2026: lecture at the Korean Society of Filler Spring Conference
• December 14–16, 2025: lecture at the Aesthetic Medicine & Surgery Conference & Exhibition Asia (AMSC Asia) in Hong Kong
• November 30, 2025: lecture at a joint academic conference of societies including the Korean Academy of Primary Healthcare
• May 25, 2025: lecture at the Korean Society of Filler Spring Conference

Learning from the experience accumulated by many medical professionals and exchanging diverse views on new treatment techniques can help broaden understanding of the decision criteria to be considered in actual clinical practice.

Whenever a new medical technology is introduced, it is also important to examine its differences from existing procedures, its indications, safety, and clinical evidence together, rather than emphasizing only the expected advantages.

Hyper Titanium: a focus on its potential for future clinical development

In aesthetic medicine recently, the importance of treatment plans tailored to an individual's skin condition, facial structure, and treatment goals, rather than uniform procedures, has been consistently emphasized.

Against this backdrop, the new Hyper Titanium protocol using two tips is drawing interest in that it may give medical professionals an additional treatment option.

However, actual clinical usefulness must be judged on the basis of each patient's indications and sufficient evidence, and comparisons with Soprano Titanium and other energy-based devices are also needed.

This '2026 Titanium Master Summit' was meaningful in that it introduced the new Hyper Titanium technology while also serving as an occasion for Korean medical professionals to exchange experience and knowledge.

The attendance of Dr. Lee, Chief Director of BLS Clinic Main Branch, at this academic event can be seen as part of ongoing efforts to keep learning about changing aesthetic medicine technology and to maintain clinical communication among medical professionals.

Attention is turning to what role energy-based laser devices, including Hyper Titanium, will play in actual clinical settings going forward.

References

• Biotimes, 'Alma Korea successfully concludes 2026 Titanium Master Summit, Hyper Titanium Launch Edition… Hyper Titanium officially launched,' October 19, 2026
• Alma Korea official site for Soprano Titanium and Hyper Titanium
• Sisram Medical 2025 Annual Report
• MFDS medical device e-civil service portal (Soprano Titanium, import license No. 20-88)